Authors
Loading...
This research demonstrates remimazolam’s potential as an ICU sedative, indicating its rapid metabolism and effects on sedation dynamics.
Kenichi Masui (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: